Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: A multicenter randomized trial

Hepatology

Volumn 32, Issue 1, 2000, Pages 36-42

  Cabré, Eduard ^b   Rodríguez Iglesias, Pilar ^b   Caballería, Joan ^b   Quer, Joan C ^b   Sánchez Lombraña, José L ^b   Parés, Albert ^b   Papo, Michel ^b   Planas, Ramon ^b   Gassull, Miquel A ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISOLONE;

ADULT; ALCOHOL LIVER CIRRHOSIS; ALCOHOL LIVER DISEASE; ARTICLE; BLEEDING; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; ENTERIC FEEDING; FEMALE; FOLLICULITIS; FOLLOW UP; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; STEROID THERAPY; TREATMENT OUTCOME; TUBE FEEDING; VOMITING;

EID: 0001835086     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2000.8627     Document Type: Article

References (47)

1. 1. Carithers RL, Herlong HF, Diehl AM, Shaw EW, Combes B, Fallon HJ, Maddrey WC. Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. Ann Intern Med 1989;110:685-690.
2. 2. Ramond MJ, Poynard T, Rueff B, Mathurin P, Theodore C, Chaput JC, Benhamou JP. A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med 1992;326:507-512.
3. 3. Mathurin P, Duchatelle V, Ramond MJ, Degott C, Bedossa P, Erlinger S, Benhamou JP, et al. Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. Gastroenterology 1996;110:1847-1853.
4. 4. Reynolds TB, Benhamou JP Blake J, Naccaratto R, Orrego H. Treatment of acute alcoholic hepatitis. Gastroenterol Int 1989;2:208-216.
5. 5. Imperiale TF, McCullough AJ. Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials. Ann Intern Med 1990;113:299-307.
6. 6. Christensen E, Gluud C. Glucocorticoids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables. Gut 1995;37:113-118.
7. 7. Maddrey WC, Boitnott JK, Bedine MS, Weber FL, Mezey E, White RI. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978;75: 193-199.
8. 8. McCullough AJ, O'Connor JFB. Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology. Am J Gastroenterol 1998;93:2022-2036.
9. 9. Nasrallah SM, Galambos JT. Aminoacid therapy of alcoholic hepatitis. Lancet 1980;2:1276-1277.
10. 10. Diehl AM, Boitnott JK, Herlong HF, Potter JJ, Van Duyn MA, Chandler E, Mezey E. Effect of parenteral amino acid supplementation in alcoholic hepatitis. HEPATOLOGY 1985;5:57-63.
11. 11. Mendenhall CL, Bongiovanni G, Goldberg SJ, Miller B, Moore J, Rouster S, Schneider D, et al. VA cooperative study on alcoholic hepatitis III: changes in protein-calorie malnutrition associated with 30 days of hospitalization with and without enteral nutritional therapy. JPEN 1985;9:590-596.
12. 12. Achord JL. A prospective randomized clinical trial of peripheral amino acid-glucose supplementation in acute alcoholic hepatitis. Am J Gastroenterol 1987;82:871-875.
13. 13. Simon D, Galambos JT. A randomized controlled study of peripheral parenteral nutrition in moderate and severe alcoholic hepatitis. J Hepatol 1988;7:200-207.
14. 14. Mezey E, Caballería J, Mitchell MC, Parés A, Herlong HF, Rodés J. Effect of parenteral aminoacid supplementation on short-term and long-term outcomes in severe alcoholic hepatitis: a randomized controlled trial. HEPATOLOGY 1991;14:1090-1096.
15. 15. Kearns PJ, Young H, García G, Blaschke T, O'Hanlon G, Rinki M, Sucher K, et al. Accelerated improvement of alcoholic liver disease with enteral nutrition. Gastroenterology 1992;102:200-205.
16. 16. Chedid A, Mendenhall CL, Gartside P, French SW, Chen T, Rabin L, VA Cooperative Study Group. Prognostic factors in alcoholic liver disease. Am J Gastroenterol 1991;86:210-216.
17. 17. Blackwelder WC. Proving the null hypothesis in clinical trials. Control Clin Trials 1982;3:345-353.
18. 18. Lieber CS. Biochemical factors in alcoholic liver disease. Semin Liver Dis 1993;13:136-153.
19. 19. Lands WEM. Cellular signals in alcohol-induced liver injury: a review. Alcoholism: Clin Exp Res 1995;19:928-938.
20. 20. Lindros KO. Alcoholic liver disease: pathobiological aspects. J Hepatol 1995;23(Suppl 1):7-15.
21. 21. Kwo PY, Lumeng L. Alcoholic liver disease. Curr Opin Gastroenterol 1998;14:234-241.
22. 22. Barnes PJ, Larin M. Nuclear factor-kappa B: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066-1071.
23. 23. Zakhari S, Szabo G. NF-kB, a prototypical cytokine-regulated transcription factor: implications for alcohol-mediated responses. Alcoholism: Clin Exp Res 1996;20:236A-242A.
24. 24. Zeldin G, Yang SQ, Yin M, Lin HZ, Rai R, Diehl AM. Alcohol and cytokine-inducible transcription factors. Alcoholism: Clin Exp Res 1996;20:1639-1645.
25. 25. Wang XD, Liu C, Chung J, Stickel F, Seitz HK, Russell RM. Chronic alcohol intake reduces retinoic acid concentration and enhances AP-1 (c-jun and C-fos) expression in rat liver. HEPATOLOGY 1998;28:744-750.
26. 26. Mathurin P, Ganne-Carrié N, Poynard T, Trinchet JC. Rôle des cytokines pro-inflammatoires dans la pathogénie de l'hepatite alcoolique. Gastroenterol Clin Biol 1998;22:311-319.
27. 27. Barnes PJ, Adcock I. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 1993;14:436-441.
28. 28. Schenker S, Bay MK. Alcohol and endotoxin: another path to alcoholic liver disease? Alcoholism: Clin Exp Res 1995;19:1364-1366.
29. 29. Llovet JM, Bartolí R, Planas R, Cabré E, Jiménez M, Urban A, Ojanguren I, et al. Bacterial translocation in cirrhotic rats. Its role in the development of spontaneous bacterial peritonitis. Gut 1994;35:1648-1652.
30. 30. Runyon BA, Squier S, Borzio M. Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis. J Hepatol 1994;21:792-796.
31. 31. Llovet JM, Bartolí R, March F, Planas R, Vinado B, Cabré E, Arnal J, et al. Translocated intestinal bacteria cause spontaneous bacterial peritonitis in cirrhotic rats: molecular epidemiologic evidence. J Hepatol 1998;28: 307-313.
32. 32. Cirera I, Suárez MJ, Navasa M, Vila J, García-Valdecasas JC, Grande L, Taurá P, et al. Traslocación bacteriana en pacientes con cirrosis hepática [Abstract]. Gastroenterol Hepatol 1997;20:81.
33. 33. Nieuwenhuijzen GAP, Deitch EA, Goris RJA. Infection, the gut and the development of multiple organ dysfunction syndrome. Eur J Surg 1996;162:259-273.
34. 34. Deitch EA. Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg 1992;216:117-134.
35. 35. Ishii K, Furudera S, Kumashiro R, Koga Y, Hamada T, Sata M, Abe H, Tanikawa K. Clinical and pathological features, and the mechanism of development in severe alcoholic hepatitis, especially in comparison with acute type fulminant hepatitis. Alcohol Alcohol 1993;28(Suppl 1B):97-103.
36. 36. Lara TM, Jacobs DO. Effect of critical illness and nutritional support on mucosal mass and function. Clin Nutr 1998;17:99-105.
37. 37. Cabré E, González-Huix F, Abad Lacruz A, Esteve M, Acero D, Fernández Bañares F, Xiol X, et al. Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics: a randomized controlled trial. Gastroenterology 1990;98:715-720.
38. 38. Hirsch S, Bunout D, De la Maza P, Iturriaga H, Petermann M, Icazar G, Gattas V, et al. Controlled trial on nutrition supplementation in out-patients with symptomatic alcoholic cirrhosis. JPEN 1993;17:119-124.
39. 39. Nanji AA, Sadrzadeh SMH, Yang EK, Fogt F, Meydani M, Dannenberg AJ. Dietary saturated fatty acids: a novel treatment for alcoholic liver disease. Gastroenterology 1995;109:547-554.
40. 40. Nanji AA, Yang EK, Fogt F, Sadrzadeh SMH, Dannenberg AJ. Medium chain triglycerides and vitamin E reduce the severity of established experimental alcoholic liver disease. J Pharmacol Exp Ther 1996;277: 1694-1700.
41. 41. Karsten S, Schäfer G, Schauder P. Cytokine production and DNA synthesis by human peripheral lymphocytes in response to palmitic, stearic, oleic, and linoleic acid. J Cell Physiol 1994;161:15-22.
42. 42. Yaqoob P, Knapper JA, Webb DH, Williams CM, Newsholme E, Calder PC. Effect of olive oil on immune function in middle-aged men. Am J Clin Nutr 1998;67:129-135.
43. 43. Cabré E, Gassull MA. Complications of enteral feeding. Nutrition 1993;9:1-9.
44. 44. Kirby DF, DeLegge MH, Fleming CR. American Gastroenterological Association technical review on tube feeding for enteral nutrition. Gastroenterology 1995;108:1282-1301.
45. 45. Silk DBA, Rees RGP, Keohane PP, Attrill H. Clinical efficacy and design changes of "fine bore" nasogastric feeding tubes: a seven-year experience involving 809 intubations in 403 patients. JPEN 1987;11:378-383.
46. 46. Rees RGP, Payne James JJ, King C, Silk DBA. Spontaneous transpyloric passage and performance of 'fine bore' polyurethane feeding tubes: a controlled clinical trial. JPEN 1988;12:469-472.
47. 47. American Gastroenterological Association Medical Position Statement: Guidelines for the use of enteral nutrition. Gastroenterology 1995;108: 1280-1281.